title: Compound heterozygosity for the Achondroplasia-hypochondroplasia FGFR3 mutations: prenatal diagnosis and postnatal outcome.
abstract: We report on a male newborn infant, a compound carrier of heterozygous mutations in the FGFR3 gene causing achondroplasia and hypochondroplasia. The mother has achondroplasia and carries the common G1138 (G380R) mutation in the FGFR3 gene; the father has hypochondroplasia due to the C1620A (N540K) mutation in the same gene. The fetus was found to carry both mutations diagnosed prenatally by amniocentesis at 17.6 weeks of gestation, following maternal serum screening which showed an increased risk for Down syndrome (1:337). Detailed fetal ultrasound studies showed a large head, short limbs, and a small chest at 22 weeks of gestation. The changes were more severe than those of either achondroplasia or hypochondroplasia. The patient was born by cesarean section at 38 weeks of gestation and had rhizomelic shortness of the upper and lower limbs with excess skin folds, large head, enlarged fontanelles, frontal bossing, lumbar gibbus, trident position of the fingers, and a narrow chest with a horizontal line of demarcation at the narrowest area of the chest. Skeletal radiographs showed shortness of the long bones and flare of metaphyses. He had respiratory difficulties and was treated with nasal prongs. Seizures developed on day 2 of life and recurred on day 9 and responded to treatment with phenobarbital. Brain computed tomographic scan showed possible grey matter heterotopia, partial agenesis of the corpus callosum, and cortical dysplasia. To our knowledge, there are only two previously published cases of compound heterozygous achondroplasia-hypochondroplasia patients. The diagnosis was confirmed by DNA mutation analysis of the FGFR3 gene in both cases.
authors.affiliation: Department of Obstetrics and Gynecology, Toronto Hospital, Ontario, Canada. dchitayat@torhosp.toronto.on.ca
authors.forename: D
authors.initials: D
authors.lastname: Chitayat
authors.forename: B
authors.initials: B
authors.lastname: Fernandez
authors.forename: A
authors.initials: A
authors.lastname: Gardner
authors.forename: L
authors.initials: L
authors.lastname: Moore
authors.forename: P
authors.initials: P
authors.lastname: Glance
authors.forename: M
authors.initials: M
authors.lastname: Dunn
authors.forename: K
authors.initials: K
authors.lastname: Chun
authors.forename: M
authors.initials: M
authors.lastname: Sgro
authors.forename: P
authors.initials: P
authors.lastname: Ray
authors.forename: D
authors.initials: D
authors.lastname: Allingham-Hawkins
mesh_terms: D000015:Abnormalities, Multiple / Q000175:diagnosis / Q000235:genetics*; D000130:Achondroplasia / Q000175:diagnosis / Q000235:genetics*; D000328:Adult; D000649:Amniocentesis; D001842:Bone and Bones / Q000000981:diagnostic imaging; D004252:DNA Mutational Analysis; D005260:Female; D051518:Fibroblast Growth Factor 3; D005346:Fibroblast Growth Factors / Q000235:genetics*; D006579:Heterozygote; D006801:Humans; D008297:Male; D009154:Mutation; D010009:Osteochondrodysplasias / Q000175:diagnosis / Q000235:genetics*; D011247:Pregnancy; D011256:Pregnancy Outcome; D011296:Prenatal Diagnosis; D011518:Proto-Oncogene Proteins / Q000235:genetics*; D011859:Radiography
chemical_list: C496444:FGF3 protein, human; D051518:Fibroblast Growth Factor 3; D011518:Proto-Oncogene Proteins; D005346:Fibroblast Growth Factors